SUNNYVALE, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today reported financial results for the fourth quarter and full year ended December 31, 2024.
Ceribell Reports Fourth Quarter and Full Year 2024 Financial Results
Seeking Alpha / 9 hours ago 4 Views
Comments